PharmatrophiX

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.

AstronauTx

This biotechnology company develops small-molecule drugs targeting astrocyte biology to treat patients with Alzheimer's disease and other neurodegenerative disorders.

Allyx

This clinical-stage biotechnology company develops oral small molecule therapies to protect synapses in patients with Alzheimer's disease and other neurodegenerative conditions.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

Cognition Therapeutics

This company develops oral small-molecule medications for patients with neurodegenerative disorders such as Alzheimer's disease and dementia with Lewy bodies.

Rodin Therapeutics

This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.

Vanqua Bio

This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.